# Baseclick

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/baseclick

- Industry: Biotechnology
- Headquarters: Munich, Germany
- Website: www.baseclick.eu
- Total disclosed funding: $1.6M
- Latest round: Series B (Aug 31, 2011)
- Investors on record: 2

## About

Baseclick GmbH is a biotechnology company specializing in the development of innovative products and services based on Click Chemistry, focusing on enhancing molecular biology applications for research and therapeutics.Founded in 2008 in Munich, Germany, Baseclick GmbH develops advanced technologies for Click Chemistry in biotechnology. The company has undergone strategic pivots to enhance its product offerings, now focusing on ligand-receptor mediated cellular targeting and mRNA synthesis solutions. Thomas Carell, the founder, has a history of involvement in multiple ventures. Baseclick has completed 3 deals, with its latest funding round being a Series B worth EUR 1.200 mn led by BASF, bringing the total amount raised to EUR 1.200 mn and a current company valuation of EUR 4.481 mn.Baseclick GmbH specializes in innovative products and services focused on Click Chemistry for the biotechnology sector. Key offerings include ClickSeq, a method for preparing next-generation sequencing (NGS) libraries, and technologies for ligand-receptor mediated cellular targeting, which enhance RNA therapeutic delivery. Their mRNA synthesis solutions stabilize modified nucleotides to ensure high-quality production. Baseclick serves a diverse clientele, including academic institutions and pharmaceutical firms across Europe and North America, with applications in research, diagnostics, and drug development.Baseclick GmbH operates on a B2B model, providing products and services primarily to research institutions and biotechnology companies. In 2014, the company reported a revenue of EUR 434,612 and an EBITDA of EUR -570,211. Their offerings, like ClickSeq kits and mRNA synthesis services, cater to both large institutional purchases and smaller orders, underscoring their alignment with client research objectives.Baseclick GmbH is focused on launching new products designed to enhance their offering in the Click Chemistry space, although specific release dates have not been disclosed. The company plans to expand into new markets in Europe and North America. Recent funding from the Series B round will be utilized to support these initiatives and further enhance their R&D capabilities, as Baseclick was sold.

## Funding rounds

- Series B, Aug 31, 2011, $1.6M — BASF, Gradus Limited

## Investors

- BASF (https://capitalatlas.ai/funds/basf) — Series B
- Gradus Limited — Series B